BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 17296835)

  • 1. Deep gray matter perfusion in multiple sclerosis: dynamic susceptibility contrast perfusion magnetic resonance imaging at 3 T.
    Inglese M; Park SJ; Johnson G; Babb JS; Miles L; Jaggi H; Herbert J; Grossman RI
    Arch Neurol; 2007 Feb; 64(2):196-202. PubMed ID: 17296835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pattern of hemodynamic impairment in multiple sclerosis: dynamic susceptibility contrast perfusion MR imaging at 3.0 T.
    Adhya S; Johnson G; Herbert J; Jaggi H; Babb JS; Grossman RI; Inglese M
    Neuroimage; 2006 Dec; 33(4):1029-35. PubMed ID: 16996280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortical Perfusion Alteration in Normal-Appearing Gray Matter Is Most Sensitive to Disease Progression in Relapsing-Remitting Multiple Sclerosis.
    Hojjat SP; Kincal M; Vitorino R; Cantrell CG; Feinstein A; Zhang L; Lee L; O'Connor P; Carroll TJ; Aviv RI
    AJNR Am J Neuroradiol; 2016 Aug; 37(8):1454-61. PubMed ID: 27012299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired cerebrovascular reactivity in multiple sclerosis.
    Marshall O; Lu H; Brisset JC; Xu F; Liu P; Herbert J; Grossman RI; Ge Y
    JAMA Neurol; 2014 Oct; 71(10):1275-81. PubMed ID: 25133874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. White matter hemodynamic abnormalities precede sub-cortical gray matter changes in multiple sclerosis.
    Varga AW; Johnson G; Babb JS; Herbert J; Grossman RI; Inglese M
    J Neurol Sci; 2009 Jul; 282(1-2):28-33. PubMed ID: 19181347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microvascular abnormality in relapsing-remitting multiple sclerosis: perfusion MR imaging findings in normal-appearing white matter.
    Law M; Saindane AM; Ge Y; Babb JS; Johnson G; Mannon LJ; Herbert J; Grossman RI
    Radiology; 2004 Jun; 231(3):645-52. PubMed ID: 15163806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thalamic Iron Differentiates Primary-Progressive and Relapsing-Remitting Multiple Sclerosis.
    Burgetova A; Dusek P; Vaneckova M; Horakova D; Langkammer C; Krasensky J; Sobisek L; Matras P; Masek M; Seidl Z
    AJNR Am J Neuroradiol; 2017 Jun; 38(6):1079-1086. PubMed ID: 28450431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral blood flow dependency on systemic arterial circulation in progressive multiple sclerosis.
    Jakimovski D; Bergsland N; Dwyer MG; Choedun K; Marr K; Weinstock-Guttman B; Zivadinov R
    Eur Radiol; 2022 Sep; 32(9):6468-6479. PubMed ID: 35359167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging perfusion is associated with disease severity and activity in multiple sclerosis.
    Sowa P; Nygaard GO; Bjørnerud A; Celius EG; Harbo HF; Beyer MK
    Neuroradiology; 2017 Jul; 59(7):655-664. PubMed ID: 28585082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perfusion magnetic resonance imaging correlates of neuropsychological impairment in multiple sclerosis.
    Inglese M; Adhya S; Johnson G; Babb JS; Miles L; Jaggi H; Herbert J; Grossman RI
    J Cereb Blood Flow Metab; 2008 Jan; 28(1):164-71. PubMed ID: 17473851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Quantitative Cerebral Blood Flow Measurements Performed by Bookend Dynamic Susceptibility Contrast and Arterial Spin-Labeling MRI in Relapsing-Remitting Multiple Sclerosis.
    D'Ortenzio RM; Hojjat SP; Vitorino R; Cantrell CG; Lee L; Feinstein A; O'Connor P; Carroll TJ; Aviv RI
    AJNR Am J Neuroradiol; 2016 Dec; 37(12):2265-2272. PubMed ID: 27686489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study.
    Pulizzi A; Rovaris M; Judica E; Sormani MP; Martinelli V; Comi G; Filippi M
    Arch Neurol; 2007 Aug; 64(8):1163-8. PubMed ID: 17698707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic Contrast-Enhanced Magnetic Resonance Imaging Suggests Normal Perfusion in Normal-Appearing White Matter in Multiple Sclerosis.
    Ingrisch M; Sourbron S; Herberich S; Schneider MJ; Kümpfel T; Hohlfeld R; Reiser MF; Ertl-Wagner B
    Invest Radiol; 2017 Mar; 52(3):135-141. PubMed ID: 27548346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3D GRASE arterial spin labelling reveals an inverse correlation of cortical perfusion with the white matter lesion volume in MS.
    Amann M; Achtnichts L; Hirsch JG; Naegelin Y; Gregori J; Weier K; Thöni A; Mueller-Lenke N; Radue EW; Günther M; Kappos L; Gass A
    Mult Scler; 2012 Nov; 18(11):1570-6. PubMed ID: 22466702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced grey matter perfusion without volume loss in early relapsing-remitting multiple sclerosis.
    Debernard L; Melzer TR; Van Stockum S; Graham C; Wheeler-Kingshott CA; Dalrymple-Alford JC; Miller DH; Mason DF
    J Neurol Neurosurg Psychiatry; 2014 May; 85(5):544-51. PubMed ID: 24039024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoperfusion of the thalamus is associated with disability in relapsing remitting multiple sclerosis.
    Doche E; Lecocq A; Maarouf A; Duhamel G; Soulier E; Confort-Gouny S; Rico A; Guye M; Audoin B; Pelletier J; Ranjeva JP; Zaaraoui W
    J Neuroradiol; 2017 Mar; 44(2):158-164. PubMed ID: 27865557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. White matter and deep gray matter hemodynamic changes in multiple sclerosis patients with clinically isolated syndrome.
    Papadaki EZ; Mastorodemos VC; Amanakis EZ; Tsekouras KC; Papadakis AE; Tsavalas ND; Simos PG; Karantanas AH; Plaitakis A; Maris TG
    Magn Reson Med; 2012 Dec; 68(6):1932-42. PubMed ID: 22367604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis.
    Calabrese M; Agosta F; Rinaldi F; Mattisi I; Grossi P; Favaretto A; Atzori M; Bernardi V; Barachino L; Rinaldi L; Perini P; Gallo P; Filippi M
    Arch Neurol; 2009 Sep; 66(9):1144-50. PubMed ID: 19752305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study.
    Bakshi R; Benedict RH; Bermel RA; Caruthers SD; Puli SR; Tjoa CW; Fabiano AJ; Jacobs L
    Arch Neurol; 2002 Jan; 59(1):62-8. PubMed ID: 11790232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging: relation to clinical characteristics in subgroups of patients with multiple sclerosis.
    van Walderveen MA; Lycklama A Nijeholt GJ; Adèr HJ; Jongen PJ; Polman CH; Castelijns JA; Barkhof F
    Arch Neurol; 2001 Jan; 58(1):76-81. PubMed ID: 11176939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.